B
Bryan Burmeister
Researcher at Princess Alexandra Hospital
Publications - 163
Citations - 8693
Bryan Burmeister is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 39, co-authored 158 publications receiving 7908 citations. Previous affiliations of Bryan Burmeister include Sir Charles Gairdner Hospital & University of Queensland.
Papers
More filters
Journal ArticleDOI
3. Radiation therapy
David Ball,Bryan Burmeister +1 more
TL;DR: Combinations of chemotherapy and radiation therapy appear to be more effective than radiation therapy alone, and sufficient evidence now exists to support combined radiation therapy and platinum‐based chemotherapy as the best standard of care for patients with good performance status and unresectable disease.
Journal ArticleDOI
Disease-free survival as a surrogate for overall survival in neoadjuvant trials of gastroesophageal adenocarcinoma: Pooled analysis of individual patient data from randomized controlled trials.
Ulrich Ronellenfitsch,Katrin Jensen,Svenja E. Seide,Meinhard Kieser,Matthias Schwarzbach,Tracy E. Slanger,Bryan Burmeister,David P. Kelsen,Donna Niedzwiecki,Guillaume Piessen,Christoph Schumacher,Susan G. Urba,Cornelis J.H. van de Velde,Marc Ychou,Ralf Hofheinz,Sylvie Lorenzen +15 more
TL;DR: This data indicates that disease-free survival is an appealing surrogate endpoint for overall survival in trials on neoadjuvant or adjuvant cancer therapy, because it is available faster and with fewer side effects than other measures of survival.
Journal Article
The complex relationship of lung tumor volume to survival in patients with non-small cell lung cancer (NSCLC) treated by definitive radiotherapy (RT): (Trans Tasman Radiation Oncology Group Study 9905)
David Ball,Richard I. Fisher,Bryan Burmeister,Michael Poulsen,Peter Graham,Michael Penniment,Shalini K Vinod,H. Krawitz,David Joseph,Greg Wheeler,Bev McClure +10 more
Journal ArticleDOI
SO-4 Individual participant data network meta-analysis (IPD-NMA) of neoadjuvant chemotherapy or chemoradiotherapy in esophageal or gastro-esophageal junction carcinoma
Matthieu Faron,Maurice Cheugoua-Zanetsie,Pierre Thirion,J. Tierney,David Cunningham,Kyle Winter,J Fu,Murielle Mauer,J. Shapiro,Bryan Burmeister,Tom Walsh,Guillaume Piessen,Fredrik Klevebro,Marc Ychou,A. van der Gaast,Simon Law,Marian Stahl,J.W. van Sandick,J.R. Pignon,Michel Ducreux,Stefan Michiels +20 more
TL;DR: In this paper , the optimal neoadjuvant treatment for resectable locally advanced carcinoma of the thoracic esophagus (TE) or gastroesophageal junction (GEJ) remains a matter of debate.
This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial
Rachael L. Morton,Anna K. Nowak,Catherine Mandel,Angela Hong,Bryan Burmeister,John F. Thompson +5 more